Invention Grant
- Patent Title: Triazole derivatives as P2Y14 receptor antagonists
-
Application No.: US15762852Application Date: 2016-09-23
-
Publication No.: US10683277B2Publication Date: 2020-06-16
- Inventor: Kenneth A. Jacobson , Anna Junker , Elisa Uliassi , Evgeny Kiselev
- Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Applicant Address: US MD Bethesda
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: US MD Bethesda
- Agency: Leydig, Voit & Mayer, Ltd.
- International Application: PCT/US2016/053397 WO 20160923
- International Announcement: WO2017/053769 WO 20170330
- Main IPC: C07D401/06
- IPC: C07D401/06 ; C07D401/10 ; C07D401/14 ; C07D211/18 ; C07D417/14 ; C07D405/14 ; C07D409/14

Abstract:
Described are compounds, which are antagonists of the P2Y14 receptor, for example, a compound of formula (I) in which ring A, R1, R2, R3, and n are as described herein. Also provided are dendron conjugates comprising the compounds, and methods of using the compounds, including a method of treating a disorder, such as inflammation, diabetes, insulin resistance, hyperglycemia, a lipid disorder, obesity, a condition associated with metabolic syndrome, and asthma, and a method of antagonizing P214 receptor activity in a cell.
Public/Granted literature
- US20180297981A1 TRIAZOLE DERIVATIVESAS P2Y14 RECEPTOR ANTAGONISTS Public/Granted day:2018-10-18
Information query